Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2017, Vol. 18 Issue (4): 277-288    DOI: 10.1631/jzus.B1600460
Reviews     
Immune response of T cells during herpes simplex virus type 1 (HSV-1) infection
Jie Zhang, Huan Liu, Bin Wei
State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Herpes simplex virus type 1 (HSV-1), a neurotropic member of the alphaherpes virus family, is among the most prevalent and successful human pathogens. HSV-1 can cause serious diseases at every stage of life including fatal disseminated disease in newborns, cold sores, eye disease, and fatal encephalitis in adults. HSV-1 infection can trigger rapid immune responses, and efficient inhibition and clearance of HSV-1 infection rely on both the innate and adaptive immune responses of the host. Multiple strategies have been used to restrict host innate immune responses by HSV-1 to facilitate its infection in host cells. The adaptive immunity of the host plays an important role in inhibiting HSV-1 infections. The activation and regulation of T cells are the important aspects of the adaptive immunity. They play a crucial role in host-mediated immunity and are important for clearing HSV-1. In this review, we examine the findings on T cell immune responses during HSV-1 infection, which hold promise in the design of new vaccine candidates for HSV-1.

Key wordsHerpes simplex virus type 1      Adaptive immunity      T cells      Vaccine     
Received: 13 October 2016      Published: 05 April 2017
CLC:  R392  
Cite this article:

Jie Zhang, Huan Liu, Bin Wei. Immune response of T cells during herpes simplex virus type 1 (HSV-1) infection. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(4): 277-288.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B1600460     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2017/V18/I4/277

[1] Feng Yao, Yuan-qiang Lu, Jiu-kun Jiang, Lin-hui Gu, Han-zhou Mou. Immune recovery after fluid resuscitation in rats with severe hemorrhagic shock[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(5): 402-409.
[2] Ai-bin Zhang, Yi-gang Qian, Shu-sen Zheng. Prognostic significance of regulatory T lymphocytes in patients with hepatocellular carcinoma[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(12): 984-991.
[3] Xinguo Jiang. Harnessing the immune system for the treatment of breast cancer[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(1): 1-15.
[4] Guo-qing Ding, Yan-lan Yu, Zhou-jun Shen, Xie-lai Zhou, Shan-wen Chen, Guo-dong Liao, Yue Zhang. Antitumor effects of human interferon-alpha 2b secreted by recombinant bacillus Calmette-Guérin vaccine on bladder cancer cells[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(5): 335-341.
[5] Jing-jing Ren, Xue-wei Dai, Zheng-gang Jiang, Ling-zhi Shen, Yong-di Chen, Qian Li, Wen Ren, Ying Liu, Jun Yao, Lan-juan Li. Immunological effects of a 10-μg dose of domestic hepatitis B vaccine in adults[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(11): 948-954.
[6] Rui CHEN, Shao-hong LU, Qun-bo TONG, Di LOU, Dong-yan SHI, Bing-bing JIA, Guo-ping HUANG, Jin-fu WANG. Protective effect of DNA-mediated immunization with liposome-encapsulated GRA4 against infection of Toxoplasma gondii[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2009, 10(7): 512-521.
[7] JIANG Qiang, ZHANG Su-zhan, PENG Jia-ping, WANG Xu-lin. Preparation and in vitro studies of microencapsulated cells releasing human tissue inhibitor of metalloproteinase-2[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2005, 6( 9): 2-.